José Federico
Díaz González
Catedrático de Universidad
Complexo Hospitalario Universitario de Santiago
Santiago de Compostela, EspañaPublicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario de Santiago (8)
2024
-
Early identification of golimumab-treated patients with higher likelihood of long-term retention
Frontiers in Immunology, Vol. 15
2023
-
Long-term retention of golimumab treatment in clinical practice in a large cohort of patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis
Musculoskeletal Care, Vol. 21, Núm. 1, pp. 189-197
2021
-
Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry
Clinical Rheumatology, Vol. 40, Núm. 10, pp. 3979-3988
-
Update of the Position Paper of the Spanish Society of Rheumatology on Biosimilar Drugs
Reumatologia Clinica, Vol. 17, Núm. 3, pp. 160-169
2019
-
Factors associated with long-term retention of treatment with golimumab in a real-world setting: an analysis of the Spanish BIOBADASER registry
Rheumatology International, Vol. 39, Núm. 3, pp. 509-515
-
Objectives and methodology of BIOBADASER phase III
Reumatologia Clinica, Vol. 15, Núm. 4, pp. 229-236
2018
-
Persistence and adverse events of biological treatment in adult patients with juvenile idiopathic arthritis: Results from BIOBADASER
Arthritis Research and Therapy, Vol. 20, Núm. 1
2010
-
Recommendations for the management of influenza A (H1N1) in rheumatic patients with immunosuppression
Reumatologia Clinica, Vol. 6, Núm. 1, pp. 63-68